PARP Inhibitor / CYP17 Inhibitor Combinations are used to treat certain types of prostate cancer. They work by decreasing levels of androgens in the body and preventing the tumor's DNA from repairing itself properly.
Why are parp inhibitor cyp17 inhibitor combinations prescribed?
NIRAPARIB; ABIRATERONE treats prostate cancer. It works by decreasing levels of the hormone testosterone in the body. It also blocks a protein that causes cancer cells to grow and multiply. This prevents prostate cancer cells from spreading or growing.
Disclaimer: Popularity is based on total prescriptions for the brand and generic versions of each drug, regardless of the condition being treated. Some drugs are prescribed for multiple conditions.
Subscribe and save
Get prescription saving tips and more from GoodRx Health. Enter your email to sign up